Trial intelligence / Profile preview

Alpha lipoic acid for pain and implantation gene expression in infertile women with endometriosis

IRCT20220817055727N1Phase 2Completed

Sponsor
Iran University of Medical Sciences
Start
Dec 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of alpha-lipoic acid in endometriosis, sponsored by Iran University of Medical Sciences. Primary endpoints: Pain intensity and Expression of implantation-related genes. Started Dec 2022; status: completed.

02

Drugs

alpha-lipoic acid
03

Conditions

endometriosis

Beyond the preview

Go deeper on IRCT20220817055727N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20220817055727N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call